NCT03722238 Actual Use and Compliance Study Of Ibuprofen 600 Mg Immediate Release/Extended Release Tablets In At-Risk OTC Consumers Status TERMINATED Phase PHASE3
NCT03720470 Study Evaluating Efficacy and Safety of PF-04965842 and Dupilumab in Adult Subjects With Moderate to Severe Atopic Dermatitis on Background Topical Therapy Status COMPLETED Phase PHASE3
NCT03719768 Avelumab With Radiotherapy in Patients With Leptomeningeal Disease Status COMPLETED Phase PHASE1
NCT03715829 A Phase 2b Study To Evaluate The Efficacy And Safety Profile Of PF-06651600 And PF-06700841 In Active Non-segmental Vitiligo Subjects Status COMPLETED Phase PHASE2
NCT03709680 Study Of Palbociclib Combined With Chemotherapy In Pediatric Patients With Recurrent/Refractory Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT03709082 Palbociclib in Estrogen Receptor Positive (ER+) Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer Status TERMINATED Phase PHASE1/PHASE2
NCT03704298 Safety and Efficacy of Axicabtagene Ciloleucel in Combination With Utomilumab in Adults With Refractory Large B-cell Lymphoma Status TERMINATED Phase PHASE1
NCT03699384 Safety and Clinical Activity Study of Combination Azacitidine and Avelumab in Patients With Acute Myeloid Leukemia (AML) and Minimal Residual Disease (MRD) Status WITHDRAWN Phase PHASE1/PHASE2
NCT03696303 Determination of the Utility of Pfizer's Pneumococcal Urine Antigen Test in Children 5 Years of Age or Younger With Community Acquired Pneumonia in Guatemala Status COMPLETED Phase N/A
NCT03693170 Encorafenib, Binimetinib and Cetuximab in Subjects With Previously Untreated BRAF-mutant ColoRectal Cancer Status COMPLETED Phase PHASE2
NCT03691493 Radiation Therapy, Palbociclib, and Hormone Therapy in Treating Breast Cancer Patients With Bone Metastasis Status COMPLETED Phase PHASE2
NCT03685591 PF-06952229 Treatment in Adult Patients With Advanced Solid Tumors Status TERMINATED Phase PHASE1
NCT03680365 Your Voice; Impact of Duchenne Muscular Dystrophy (DMD) on the Lives of Families Status COMPLETED Phase N/A
NCT03677596 A Study Of Two Inotuzumab Ozogamicin Doses in Relapsed/ Refractory Acute Lymphoblastic Leukemia Transplant Eligible Patients Status COMPLETED Phase PHASE4
NCT03674528 Technical Validation of MR Biomarkers of Obesity-Associated NAFLD Status COMPLETED Phase N/A
NCT03672773 Talazoparib and Low-Dose Temozolomide in Treating Participants With Relapsed or Refractory Extensive-Stage Small Cell Lung Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2